200 related articles for article (PubMed ID: 27445409)
1. Synergy: karyotypes and mutations in CLL.
Abruzzo LV
Blood; 2016 Jul; 128(3):319-20. PubMed ID: 27445409
[TBL] [Abstract][Full Text] [Related]
2. Major prognostic value of complex karyotype in addition to TP53 and IGHV mutational status in first-line chronic lymphocytic leukemia.
Le Bris Y; Struski S; Guièze R; Rouvellat C; Prade N; Troussard X; Tournilhac O; Béné MC; Delabesse E; Ysebaert L
Hematol Oncol; 2017 Dec; 35(4):664-670. PubMed ID: 27678008
[TBL] [Abstract][Full Text] [Related]
3. Extensive next-generation sequencing analysis in chronic lymphocytic leukemia at diagnosis: clinical and biological correlations.
Rigolin GM; Saccenti E; Bassi C; Lupini L; Quaglia FM; Cavallari M; Martinelli S; Formigaro L; Lista E; Bardi MA; Volta E; Tammiso E; Melandri A; Urso A; Cavazzini F; Negrini M; Cuneo A
J Hematol Oncol; 2016 Sep; 9(1):88. PubMed ID: 27633522
[TBL] [Abstract][Full Text] [Related]
4. [Trisomy 8 in chronic lymphocytic leukemia].
Cao X; Xu W; Liu Q; Zhu DX; Qiao C; Wu YJ; Qiu HX; Li JY
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2009 Aug; 26(4):443-5. PubMed ID: 20017313
[TBL] [Abstract][Full Text] [Related]
5. Isolated 13q14 abnormalities and normal karyotypes are associated with typical lymphocyte morphology in B-cell chronic lymphocytic leukemia.
Kroft SH; Finn WG; Kay NE; Peterson LC
Am J Clin Pathol; 1997 Mar; 107(3):275-82. PubMed ID: 9052377
[TBL] [Abstract][Full Text] [Related]
6. Combined cytogenetic testing and fluorescence in situ hybridization analysis in the study of chronic lymphocytic leukemia and multiple myeloma.
Wiktor A; Van Dyke DL
Cancer Genet Cytogenet; 2004 Aug; 153(1):73-6. PubMed ID: 15325099
[TBL] [Abstract][Full Text] [Related]
7. The parallel application of karyotype interphase and metaphase FISH after DSP-30/IL-2 stimulation is necessary for the investigation of chronic lymphocytic leukemia.
Karakosta M; Manola KN
Hematology; 2016 Oct; 21(9):526-35. PubMed ID: 27077766
[TBL] [Abstract][Full Text] [Related]
8. Complex karyotypes and KRAS and POT1 mutations impact outcome in CLL after chlorambucil-based chemotherapy or chemoimmunotherapy.
Herling CD; Klaumünzer M; Rocha CK; Altmüller J; Thiele H; Bahlo J; Kluth S; Crispatzu G; Herling M; Schiller J; Engelke A; Tausch E; Döhner H; Fischer K; Goede V; Nürnberg P; Reinhardt HC; Stilgenbauer S; Hallek M; Kreuzer KA
Blood; 2016 Jul; 128(3):395-404. PubMed ID: 27226433
[TBL] [Abstract][Full Text] [Related]
9. Karyotype and outcome in CLL.
Mulligan SP
Blood; 2023 Aug; 142(5):402-404. PubMed ID: 37535371
[No Abstract] [Full Text] [Related]
10. [A case of Richter syndrome transformed from chronic lymphocytic leukemia with karyotype aberration of trisomy 12].
Xu ZS; Zhang JY; Zhan R; Zheng ZH; Wu SQ; Chen ZZ
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2012 Apr; 20(2):287-90. PubMed ID: 22541083
[TBL] [Abstract][Full Text] [Related]
11. Chronic lymphocytic leukemia with isochromosome 17q: An aggressive subgroup associated with TP53 mutations and complex karyotypes.
Collado R; Puiggros A; López-Guerrero JA; Calasanz MJ; Larráyoz MJ; Ivars D; García-Casado Z; Abella E; Orero MT; Talavera E; Oliveira AC; Hernández-Rivas JM; Hernández-Sánchez M; Luño E; Valiente A; Grau J; Portal I; Gardella S; Salgado AC; Giménez MT; Ardanaz MT; Campeny A; Hernández JJ; Álvarez S; Espinet B; Carbonell F
Cancer Lett; 2017 Nov; 409():42-48. PubMed ID: 28888994
[TBL] [Abstract][Full Text] [Related]
12. Comparison of chromosomal rearrangements in bone marrow cells and blast transformed B-cells in relapse of B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma.
Andreieva SV; Korets KV; Ruzhinska OE; Skorokhod IM; Alkhimova OG
Exp Oncol; 2017 Jul; 39(2):141-144. PubMed ID: 29483496
[TBL] [Abstract][Full Text] [Related]
13. No evidence of trisomy 12 or t(11;14) by molecular genetic techniques in chronic lymphocytic leukemia cells with a normal karyotype.
Einhorn S; Meeker T; Juliusson G; Burvall K; Gahrton G
Cancer Genet Cytogenet; 1990 Sep; 48(2):183-92. PubMed ID: 2397450
[TBL] [Abstract][Full Text] [Related]
14. TP53 mutations are early events in chronic lymphocytic leukemia disease progression and precede evolution to complex karyotypes.
Lazarian G; Tausch E; Eclache V; Sebaa A; Bianchi V; Letestu R; Collon JF; Lefebvre V; Gardano L; Varin-Blank N; Soussi T; Stilgenbauer S; Cymbalista F; Baran-Marszak F
Int J Cancer; 2016 Oct; 139(8):1759-63. PubMed ID: 27270786
[TBL] [Abstract][Full Text] [Related]
15. [Chromosome study on chronic lymphocytic leukemia using CpG-oligodeoxynucleotide as immunostimulant agent].
Wu Y; Xue Y; Chen S; Yao L; Jiang H; Zhang J; Shen J; Pan J; Wang Y; Bai S
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2010 Feb; 27(1):86-91. PubMed ID: 20140876
[TBL] [Abstract][Full Text] [Related]
16. Cytogenetic and molecular genetic studies on Indian patients with chronic lymphocytic leukemia.
Kumaravel TS; Chendil D; Arif M; Asou H; Bharadwaj TP; Sethuraman S; Susheela M; Raina V; Bhargava M; Pant GS; Tanaka K; Murthy PB; Kamada N
Int J Hematol; 1996 Jul; 64(1):31-7. PubMed ID: 8757965
[TBL] [Abstract][Full Text] [Related]
17. FISHing in the dark: How the combination of FISH and conventional karyotyping improves the diagnostic yield in CpG-stimulated chronic lymphocytic leukemia.
Dubuc AM; Davids MS; Pulluqi M; Pulluqi O; Hoang K; Hernandez-Sánchez JM; Schlich C; Hernández-Rivas JM; Brown JR; Dal Cin P
Am J Hematol; 2016 Oct; 91(10):978-83. PubMed ID: 27341486
[TBL] [Abstract][Full Text] [Related]
18. Aberrant levels of SUV39H1 and SUV39H2 methyltransferase are associated with genomic instability in chronic lymphocytic leukemia.
Carvalho Alves-Silva J; do Amaral Rabello D; Oliveira Bravo M; Lucena-Araujo A; Madureira de Oliveira D; Morato de Oliveira F; Magalhaes Rego E; Pittella-Silva F; Saldanha-Araujo F
Environ Mol Mutagen; 2017 Dec; 58(9):654-661. PubMed ID: 28833505
[TBL] [Abstract][Full Text] [Related]
19. Chromosomal abnormalities in B-CLL.
Oscier DG; Fitchett M; Hamblin TJ
Nouv Rev Fr Hematol (1978); 1988; 30(5-6):397-8. PubMed ID: 3222150
[TBL] [Abstract][Full Text] [Related]
20. Gain of the short arm of chromosome 2 (2p gain) has a significant role in drug-resistant chronic lymphocytic leukemia.
Kostopoulou F; Gabillaud C; Chapiro E; Grange B; Tran J; Bouzy S; Degaud M; Ghamlouch H; Le Garff-Tavernier M; Maloum K; Choquet S; Leblond V; Gabarre J; Lavaud A; Morel V; Roos-Weil D; Uzunov M; Guieze R; Bernard OA; Susin SA; Tournilhac O; Nguyen-Khac F;
Cancer Med; 2019 Jun; 8(6):3131-3141. PubMed ID: 31066214
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
